在ST段-升高心肌梗塞中错过了纤维解析的机会:全国性的法国-PCI注册表
Louis-Marie Desroche1,2, Matthieu Daniel3,4,5, Etienne Puymirat6,7
1Cardiology Department, University Hospital of La Réunion, Saint-Denis, France.
European heart journal. Quality of care & clinical outcomes
|March 13, 2026
概括
超过一半的符合条件的ST段升高心肌梗塞 (STEMI) 患者经历了延迟的再注射治疗,错过了及时纤维素分解的机会. 这凸显了持续的护理差距,需要为医院前分拣和再输注策略提供系统级质量指标.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 医疗保健服务研究 医疗服务研究
背景情况:
- 及时的再输血对于ST段升高心肌梗塞 (STEMI) 管理至关重要.
- 如果从第一次医疗接触 (FMC) 延迟超过120分钟,指导方针建议进行纤维解析.
- 在STEMI护理中错过了纤维素分解的机会需要量化.
研究的目的:
- 在全国性的STEMI网络中量化纤维解析的错失机会.
- 评估反策略的时间趋势和区域差异.
- 评估错过纤维素分解对患者结局的影响.
主要方法:
- 在法国-PCI注册表 (2014-2022) 中连续STEMI患者的分析.
- 最初的再输血被分类为及时的PPCI (≤120分钟),延迟的PPCI (>120分钟) 或纤维解.
- 对延迟PPCI患者的纤维溶解资格标准的评估 (没有口服抗凝剂,没有先前的中风,没有禁忌).
主要成果:
- 在19472名STEMI患者中,64.9%接受了及时的PPCI,30.3%的PPCI延迟,4.8%的纤维解析.
- 超过一半 (55.6%) 符合严格纤维解析标准的延迟PPCI患者是早期呈现者 (症状至心电图≤3小时).
- 这种遗漏的纤维解剖缺口保持稳定,区域差异很大;纤维解剖的使用受到了移动重症监护室和直升机运输的青.
结论:
- 在接受延迟PPCI的符合条件的STEMI患者中,很大一部分代表了纤维素分解的错失机会.
- 在反策略中存在着持续的区域异质性,这表明在准则遵守方面存在差距.
- 延迟PCI和遗漏纤维素分解的例行审计对于改善医院前分组和实现再注射目标至关重要.
相关概念视频
01:16Clot Retraction and Fibrinolysis
9.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.9K
01:30Acute Coronary Syndrome I: Introduction
1.4K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
01:28Acute Coronary Syndrome IV: Interprofessional Care
376
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
01:30Acute Coronary Syndrome III: Diagnostic Studies
365
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
365
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
620
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
620
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K